86 results
424B3
MRZM
Marizyme, Inc.
16 Nov 23
Prospectus supplement
6:08am
(includes related party amounts of $72,000, $163,200, $216,000 and $266,400 respectively)
Salary expenses
Research and development
Stock-based … and Development Expenses and Accruals
All research and development costs are expensed in the period incurred and consist primarily of salaries, payroll taxes
424B3
MRZM
Marizyme, Inc.
17 Oct 23
Prospectus supplement
5:10pm
our research and development initiatives and take additional measures to reduce costs in order to conserve our cash in amounts sufficient to sustain … of disciplines, including research and development, clinical trials, medical matters, government regulation medical devices, manufacturing
8-K
EX-10.1
8sortvs ldpy34ta
16 Nov 21
Marizyme Is Pleased to Announce the Appointment of David Barthel As Ceo
5:00pm
8-K
EX-2.1
fiu67j68q2jgo2icrxv
5 Nov 21
Entry into a Material Definitive Agreement
5:17pm